New 52 Week Low Today

Kringle Pharma Inc 4884.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
1,003.00quote price arrow up+8.00 (+0.80%)
Volume
32,700
52 week range
980.00 - 1,780.00

...

Loading . . .

KEY STATS

  • Open1,001.00
  • Day High1,003.00
  • Day Low980.00
  • Prev Close995.00
  • 52 Week High1,780.00
  • 52 Week High Date12/28/20
  • 52 Week Low980.00
  • 52 Week Low Date02/25/21
  • Market Cap41.04M
  • Shares Out4.23M
  • 10 Day Average Volume26,860
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-236.40
  • P/E (TTM)-4.24
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Kringle Pharma Inc News

There is no recent news for this security.

Latest 4884.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Kringle Pharma Inc is a Japan-based company mainly engaged in the development of pharmaceuticals. The Company is involved in the research and development of therapeutic agents for intractable diseases using hepatocyte growth factor (HGF) protein. HGF has versatile bioactivity that is responsible for tissue or organ regeneration and protection such as cell proliferation promotion, cell motility promotion, anti-apoptosis, morphogenesis induction, and angiogenesis. HGF has a...
Kunio Iwatani
President
Tomoya Shimojo
Chief Financial Officer
Address
207
Saito Bio Incubator, 7-7-15, Saitoasagi
Ibaraki-shi, OSK
567-0085
Japan